BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synageva BioPharma 

Corporate Offices
128 Spring Street, Suite 520
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-890-1111 Fax: 781-890-1114


SEARCH JOBS



Synageva BioPharma is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need. Our lead program, SBC-102, an enzyme replacement therapy for LAL Deficiency, is currently being evaluated in global Phase I/II clinical trials. SBC-102 has been granted orphan designations by the U.S. Food and Drug Administration (“FDA”) and the European Medicines Agency and fast track designation by the FDA. Synageva has several protein therapeutics focused on life threatening conditions in its pipeline. The Company has assembled a team with a proven record of bringing orphan therapies to patients.


 Key Statistics


Email: info@synageva.com
Ownership:

Web Site: Synageva BioPharma
Employees:
Symbol: GEVA
 









 Company News
Synageva BioPharma (GEVA) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/2/2014 1:27:43 PM
Synageva BioPharma (GEVA) To Present At The Baird 2014 Healthcare Conference 8/26/2014 9:32:42 AM
Synageva BioPharma (GEVA) To Present At Upcoming Investor Conferences 8/4/2014 6:36:04 AM
Synageva BioPharma (GEVA) Reports Second Quarter 2014 Financial Results 7/31/2014 8:28:22 AM
Synageva BioPharma (GEVA) Details Positive Phase 3 Data Of Sebelipase Alfa 7/1/2014 7:22:04 AM
Synageva BioPharma (GEVA) Highlights Data Presentations And Satellite Symposium At The European Atherosclerosis Society Congress 6/3/2014 6:38:36 AM
Synageva BioPharma (GEVA) To Present At The Jefferies and Co. And Goldman, Sachs & Co. Healthcare Conferences 5/28/2014 6:45:45 AM
Synageva BioPharma (GEVA) Announces Satellite Symposium At The National Lipid Association 5/2/2014 9:40:39 AM
Synageva BioPharma (GEVA) Reports First Quarter 2014 Financial Results 5/1/2014 2:44:54 PM
Synageva BioPharma (GEVA) Release: LAL Deficiency Disease Review Published In Atherosclerosis 4/21/2014 9:37:22 AM
12345678910